Holter ECG Monitoring

Holter ECG monitoring is a diagnostic method that continuously records the electrical activity of the heart over an extended period using a portable device. At CardioPrima, the investigation can be performed for periods ranging from 24 hours up to 7 days, using 7 or 12 leads, allowing for a detailed and highly accurate analysis of heart rhythm.

When Holter ECG monitoring is recommended

• in patients with palpitations, sensations of irregular heartbeats, or episodes of loss of consciousness;
• for detecting cardiac arrhythmias that are not present during a resting ECG;
• for evaluating the effectiveness of antiarrhythmic treatment or implanted devices (stent, pacemaker);
• in patients with structural or ischemic heart disease;
• for monitoring the risk of cardiac events in patients with predisposing factors.

How the investigation is performed

• Electrodes are placed on the patient’s chest and connected to a small portable recording device.
• The device continuously records the heart’s electrical activity for the prescribed period (24 hours to 7 days).
• The patient continues normal daily activities and records any symptoms in a diary.
• After completion, the recording is analyzed by the physician, who correlates reported symptoms with rhythm changes.

Information provided by Holter ECG monitoring

• detection and classification of arrhythmias (extrasystoles, tachycardia, atrial fibrillation, etc.);
• identification of cardiac conduction disorders;
• correlation of symptoms with heart rhythm abnormalities;
• evaluation of treatment effectiveness or cardiac device performance.

Benefits for the patient

Holter ECG monitoring is a non-invasive, painless, and safe investigation that provides essential information for accurate diagnosis and treatment planning. The option of extended monitoring for up to 7 days significantly increases the likelihood of detecting rare or intermittent arrhythmias.